logo
logo

Plus Therapeutics raised up to $18 million in private placement financing

May 06, 2024•about 1 year ago

Amount Raised

$18 Million

AustinHealth Care

Investors

Aigh Capital Management Llc

Description

Plus Therapeutics, Inc. today announced a private placement financing of up to approximately $18 million. The financing includes participation from new institutional investors, Company insiders, and AIGH Capital Management LLC with additional participation from new healthcare-focused institutional investors.

Company Information

Company

Plus Therapeutics

Location

4200 MARATHON BLVD.

Austin, Texas, United States

About

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes for patients. Combining image-guided local beta radiation and targeted drug delivery approaches, the Company is advancing a pipeline of product candidates with lead programs in recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). The Company has built a supply chain through strategic partnerships that enable the development, manufacturing and future potential commercialization of its products. Plus Therapeutics is led by an experienced and dedicated leadership team and has operations in key cancer clinical development hubs, including Austin and San Antonio, Texas.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People